Monday, October 31, 2011
The order broadens reporting of potential shortages of certain prescription drugs; speeds reviews of applications to begin or alter production of these drugs; and provides more information to the Justice Department about possible instances of collusion or price gouging.
Updated: Monday at 1:19pm (ET)
There were Congressional hearings leading to the President's decision of this Executive Order. This order will begin to bring down the cost of health care and VASTLY improve the drug supply in the USA of vital drugs needed for treatment of diseases such as cancer. In the hearings it was noted that cancer studies had to be put on hold imperiling hope for the participants and ultimately changing the treatment regime for the trials. It isn't right. The pharmaceutical industry should not be dictating the path of medicine to citizens, it should be the other way around. The demand by the physicians needs to be responded to by the industry. The system previous to this order was not allowing for 'the best path' of treatment and compromising doctors and their patients.
In testimony regarding the treatment of chronic disease this statement was made:
...The passage of the Affordable Care Act (click here) and with it the creation of the Prevention and Public Health Fund represents one of the most important actions by Congress and the Federal government to promote prevention to improve the overall health and well-being of the American people. It manifests an unprecedented commitment to ensuring that all Americans are able to achieve their potential by realizing the highest standard of health....
Besides the drugs the President mentioned, there is a very distrubing reality in that a chemoctheraputic agent, known as 5-FU has noted to be in very short supply. 5-FU has been around for decades and has a long track record of treatment with success. It was one of the drugs that had to be abandoned in a 'treatment regime' under study in a trial for advanced treatement. It is an outrage and I could not believe my ears when I heard it.
There were Congressional hearings leading to the President's decision of this Executive Order. This order will begin to bring down the cost of health care and VASTLY improve the drug supply in the USA of vital drugs needed for treatment of diseases such as cancer. In the hearings it was noted that cancer studies had to be put on hold imperiling hope for the participants and ultimately changing the treatment regime for the trials. It isn't right. The pharmaceutical industry should not be dictating the path of medicine to citizens, it should be the other way around. The demand by the physicians needs to be responded to by the industry. The system previous to this order was not allowing for 'the best path' of treatment and compromising doctors and their patients.
In testimony regarding the treatment of chronic disease this statement was made:
...The passage of the Affordable Care Act (click here) and with it the creation of the Prevention and Public Health Fund represents one of the most important actions by Congress and the Federal government to promote prevention to improve the overall health and well-being of the American people. It manifests an unprecedented commitment to ensuring that all Americans are able to achieve their potential by realizing the highest standard of health....
Besides the drugs the President mentioned, there is a very distrubing reality in that a chemoctheraputic agent, known as 5-FU has noted to be in very short supply. 5-FU has been around for decades and has a long track record of treatment with success. It was one of the drugs that had to be abandoned in a 'treatment regime' under study in a trial for advanced treatement. It is an outrage and I could not believe my ears when I heard it.
5-FU Added to Drug Shortage List (click here)
Posted by on August 17th, 2011
This morning the FDA added fluorouracil to its drug shortage list. The American Society of Healthcare Pharmacists (ASHP) has also reported a shortage of fluorouracil (5-FU), a common backbone drug for colorectal cancer chemotherapy.
Two manufacturers have some doses of the drug on intermittent back order and are shipping it as it becomes available. A third has all dose vials on back order and estimates shipping sometime in the fourth quarter of 2011.
This morning the FDA added fluorouracil to its drug shortage list. The American Society of Healthcare Pharmacists (ASHP) has also reported a shortage of fluorouracil (5-FU), a common backbone drug for colorectal cancer chemotherapy.
Two manufacturers have some doses of the drug on intermittent back order and are shipping it as it becomes available. A third has all dose vials on back order and estimates shipping sometime in the fourth quarter of 2011.
